Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
$3 by August. EASY. GLTA
More good news!
In a new filing today, AEMD is also writing down the sellable price of previous warrants to $3.95. We can all consider this the new cap:
http://secfilings.nasdaq.com/filingFrameset.asp?FilingID=11949702&RcvdDate=3/23/2017&CoName=AETHLON MEDICAL INC&FormType=424B5&View=html
Way to go JJ!
Congrats Longs!
Aethlon just sold a bunch of new shares at $3.50!
http://secfilings.nasdaq.com/filingFrameset.asp?FilingID=11947155&RcvdDate=3/22/2017&CoName=AETHLON%20MEDICAL%20INC&FormType=8-K&View=html
Now THAT's useful technology. Aethlon should initiate another costly study to validate how 15 years of useless, made-for-press-release studies have resulted in the loss of any chance to ever sell a hemopurifier because...drumroll...technology moves forward and there are better, less costly and available solutions to virtually ALL of the fields of play that Aethlon pretends to play in.
New all-time low here we come Bwahahahahahahah
Hate to say "I told you so" but..."I told you so"! $3.88 close...
My $3 target for August is firmly in place. Let's see how fraudulent it is...
Just wait a few hours/days...You'll see how right I was.
$3 August target still good.
No, actually I know all about it your position on the stock...just by reading your posts.
SELL THIS BUMP (ANYTHING OVER $4).
Yes, that's one of the posts he's referring to.
For years, my general long-term opinion on the stock has been extremely negative, as well all know. And we all know what the stock has done over the last several years, being now near an all-time low. My accuracy long term is undeniable.
But, if we just look at the post you provided from 1/31, let's evaluate:
1) My post clearly states "I have changed my mind SHORT TERM"
2) the stock opened at $3.99 that day
3) by the end of the week on 2/3, the stock closed at $4.51, representing a 13% gain in just a few days.
You might benefit from focusing on effectively trading the stock instead of leveling mis-placed anger at correct albeit inconvenient opinions that seem to educate you less and anger you more as a long term loser on the stock.
Good NASDAQ Listing Requirements Summary
http://venturelawcorp.com/listing-requirements-nasdaq/
AEMD Trending Toward All-Time Low of $2.68
Yes, I make comments from both sides. It's called fair and balanced commentary. If you just want the one-sided commentary that supports your position, don't go to a message board - just subscribe to Jim Joyce's press releases. This will get you far...
Hey look - I was just making an observation when I said "nobody is buying the hype anymore...". I was expecting more of a "thank you, Captain Obvious" response but OK...
Fact is, press releases with results from Aethlon's studies used to drive the stock price higher - at least for a few weeks. Which turned into a few days. Which turned into a few hours...
JJ and company have "cried wolf" too many times and nobody is buying it and nobody will buy it unless and until some REAL RESULTS involving the FDA, some partnership or acquisition and/or God forbid -- REVENUE!
These are facts. Whether I'm in or not in has nothing to do with it...
Unfortunately nobody is buying the hype anymore...
Not really. But I am expecting a positive experience during and after the earnings call later this month. I've said all along I think 1) the bad news is all priced in and then some 2) management will shortly begin to provide positive updates on Series 6 3) Series 6 will exceed expectations on efficiency 4) the timing provided by management for Series 6 was a worst case scenario 5) Trump will actually be GOOD for FSLR due to his tax policy including import taxes on China. I also think the timing for FSLR's revamp to Series 6 was extremely lucky and they will now look to expand capacity in the US based on Trump (it would have been Malasia or Mexico) and 6) I think two new deals in Australia are just the beginning 7)the long-term trend in solar is in-tact
I could go on and on.............
Rumor Mill
Rumor Mill
How do you manipulate a message board? Bahahaha
Ahh The old "we can't show any real progress so let's start a string of insider buys to try to prop up the stock price so we don't get delisted" strategy. Brilliant.
Large new win for FSLR announced!
https://finance.yahoo.com/news/first-solar-awarded-140mw-module-220000805.html
ITEM 3.01 Notification of Failure to Satisfy a Continued Listing Rule or Standard
On February 1, 2017, Aethlon Medical, Inc. (the “Company”) received a written notification from the Nasdaq Stock Market LLC that it has not met the minimum of $35,000,000 in Market Value of Listed Securities (“MVLS”) for the last 30 consecutive business days (from December 15, 2016-January 31, 2017) as set forth in Listing Rule 5550(b)(2).
The notification does not result in the delisting of the Company's common stock at this time, and its common stock will continue to trade on the Nasdaq Capital Market.
The Company has been provided with a 180 calendar day period (by July 31, 2017) in which to gain compliance by closing with an MVLS of at least $35,000,000 for any 10 consecutive business days during that period, and this matter would then be automatically closed.
Ugh...Quarterly Investor calls at 4:30 Eastern on Friday are NEVER good
Saudis ramping up for massive solar energy buying binge...FSLR will be front and center
https://www.thestreet.com/story/13973513/1/3-ways-for-investors-to-profit-from-a-solar-energy-rebound.html
Changing my mind on AEMD
There are some key developments that have changed my mind on AEMD in the short term:
1) Short interest is at a year+ low
2) ADV is ramping significantly in the last week
3) The newly announced CTE study is a pre-determined success, based on the 2015 prelim CTE investigation data which definitively proved the efficacy of the Aethlon technology as a diagnostic tool for CTE in a small number of subjects
4)the announced "awareness campaign" leading up to the SB will generate interest in the shares
I believe the new study will fill up rather quickly and based on the nature of the study can result in positive results being reported out by the company in a matter of weeks, once it commences in Q2.
Short interest in AEMD at it's lowest point in over 12 months:
http://www.nasdaq.com/symbol/aemd/short-interest
Looks like some pin-action is coming...
Superbug More Widespread Than Previously Known
http://www.cnn.com/2017/01/16/health/cre-superbug-disease-study/
New Superbug Kills Woman in US
http://www.nbcnews.com/health/health-news/nevada-woman-died-near-ultimate-superbug-n706641
Hmmm The HP does work on bacterial toxins...
First Solar Upgraded to "Strong Buy" at VETR
https://sportsperspectives.com/2017/01/11/vetr-inc-upgrades-first-solar-inc-fslr-to-strong-buy/
Aethlon May Actually Have Another Potential Alzheimer's FOP
http://www.news-medical.net/news/20170112/Could-pathogen-infection-really-lead-to-Alzheimere28099s.aspx
As I stated before...
I believe the management at FSLR has set the table for incremental positive progress updates on the Series 6 start-of-production and efficiency data. I also believe that these updates will commence shortly, which should have a positive impact on the stock.
GLTA
Apple Product?
Is Apple making a self-driving, smart, hovercraft, compatible with the current infrastructure, capable of travelling overhead stopped vehicles, with V2x and V2V collision avoidance technology, that will forever end traffic jams and change completely the way we travel? Cook is a huge fan of the Jetson's...
Potential Windfall for AEMD?
http://www.collegeathleteconcussionsettlement.com/
Let's see if they can capitalize...
Open Question to James Joyce, CEO of Aethlon Medical:
Seven years ago, Aethlon Medical was granted FDA permission to export their Hemopurifier to India. At the time, JJ commented:
"The granting of our export license by FDA represents a critical step in our strategy to initiate future commercialization of our Hemopurifier® in India," stated Jim Joyce, Aethlon Chairman and CEO.
How's that strategy going, JJ? To date you haven't sold a sing HP to India or any other country. Care to comment?
More Dilution Announced Yesterday!
I know the old penny stock habits are hard to break and you like to sneak it in when you think nobody will notice JJ (like around holidays)...but we noticed:
http://secfilings.nasdaq.com/filingFrameset.asp?FilingID=11758581&RcvdDate=12/30/2016&CoName=AETHLON%20MEDICAL%20INC&FormType=8-K&View=html
Forecast for $3 stock price by August firmly in tact...